Horse /

Breed profile · FDA CVM July 2026 extract

Paint adverse-event record

Adverse-event filings for Paint (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

Verify with FDA CVM →
#153 of 510
by report volume (all breeds)
386
FDA CVM reports on file
13.7%
death-coded share of reports
#30 of 275
by death-coded share (≥50 reports)

How the 386 reports break down

By recorded gender -- every report on file for Paint, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 29 21.75 14.5 7.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Paint drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Paint ranks #153 of 510 by total reports (386) and #30 of 275 by death-coded share (13.7%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#153
This breed, reports of 510
#30
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Paint has 386 reports now versus 379 in that prior snapshot: 7 more (1.8%).

Report change
+7
Death-coded reports
+2
Death-coded share
+0.3 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Paint changes

Total Reports

386

Above-median volume

Deaths Reported

53

of 386 reports

Death-coded share of reports

13.7%

High death-coded share

Avg Age at Report

14.3 yr

429.1 kg avg weight

Breed Safety Scorecard

F (33/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate F
13.7%

Share of reports coded as a fatality

Euthanasia rate F
7.0%

Share of reports resulting in euthanasia

Full recovery rate A-
36.0%

Share of reports coded "Recovered/Normal"

5-year trend C+
-5%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Paint death-coded reports 13.7%
Cross-breed median

13.7% of 386 paint reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Paint's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

14% 89th percentile Higher share than 89% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). Below this entry. 20%–25%: 2 indexed breeds (1%). Below this entry. 25%–30%: 3 indexed breeds (1%). Below this entry. 30%–35%: 4 indexed breeds (1%). Below this entry. 35%–40%: 5 indexed breeds (2%). Below this entry. 40%–45%: 6 indexed breeds (2%). Below this entry. 45%–50%: 3 indexed breeds (1%). Below this entry. 50%–55%: 7 indexed breeds (3%). Below this entry. 55%–60%: 7 indexed breeds (3%). Below this entry. 60%–65%: 21 indexed breeds (8%). Below this entry. 65%–70%: 11 indexed breeds (4%). Below this entry. 70%–75%: 15 indexed breeds (5%). Below this entry. 75%–80%: 13 indexed breeds (5%). Below this entry. 80%–85%: 11 indexed breeds (4%). Below this entry. 85%–90%: 12 indexed breeds (4%). Below this entry. 90%–95%: 12 indexed breeds (4%). Below this entry. 95%–100%: 142 indexed breeds (52%). This entry sits in this band. Paint 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 429.1 kg (946.2 lbs)

Top Reported Reactions

Lack of efficacy - NOS 44
Injection site swelling 32
Death by euthanasia 24
Behavioural disorder NOS 23
Anorexia 23
Colic 22
Lethargy (see also Central nervous system depression in 'Neurological') 20
INEFFECTIVE, GASTRIC ULCER(S) 20

Most Referenced Drugs

Ceftiofur Crystalline Free Acid 41
Omeprazole 40
Pergolide Mesylate 34
Ivermectin(1.55%)/Praziquantel(7.75%) Paste 29
Polysulfated Glycosaminoglycan 23
Firocoxib 22
Ivermectin + Praziquantel 17
Detomidine Hydrochloride 16

Outcome Breakdown

Recovered/Normal
139 (39.7%)
Outcome Unknown
104 (29.7%)
Ongoing
50 (14.3%)
Euthanized
27 (7.7%)
Died
26 (7.4%)
Recovered with Sequela
4 (1.1%)

Gender Distribution

Male 214 (55.4%)
Female 161 (41.7%)
Unknown 8 (2.1%)
Mixed 3 (0.8%)

Reports by Year

Year Reports Trend
2010 22
2011 21
2012 20
2013 20
2014 28
2015 35
2016 30
2017 26
2018 19
2019 24
2020 18
2021 21
2022 24
2023 23
2024 29
2025 20
2026 6

Paint: high death-coded share in the FDA CVM extract

Signature read: Paint's 13.7% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Paint sits at #153 of 510 by report volume among all breeds and #6 of 55 among horse breeds, with 386 reports and 53 (13.7%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #30 of 275. Mean age at report: 14.3 years, average weight 429.1 kg (946.2 lbs).

Top reported signs: Lack of efficacy - NOS (44), Injection site swelling (32), Death by euthanasia (24). Most-referenced drug: Ceftiofur Crystalline Free Acid (41 reports), followed by Omeprazole (40) and Pergolide Mesylate (34).

Outcome coding on 350 status-recorded reports is dominated by Recovered/Normal (39.7%). Annual submissions ranged 6-2,026 across 17 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Arab
467 reports · 9.6% death-coded
Horse (other)
296 reports · 9.8% death-coded
Warmblood (unspecified)
541 reports · 7.0% death-coded
Crossbred Equine/horse
190 reports · 7.9% death-coded
Tennessee Walking Horse
186 reports · 12.9% death-coded
Warmblood - Dutch
184 reports · 2.7% death-coded

Nationwide breeds with similar profiles

High-volume peer sets for Paint drawn from openFDA outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (13.7% death-coded here).

Rex - Devon 13.6% · Cat Sphynx 13.6% · Cat Domestic (unspecified) 13.4% · Cat European 13.0% · Cat

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Paint? ▼
There are 386 adverse event reports involving Paint in the FDA database, of which 53 were death-coded (13.7% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Paint ranks #153 of 510 by report volume among all breeds PlainBreed indexes (#6 of 55 among horse breeds).
Where does Paint sit among other breeds in PlainBreed's corpus? ▼
According to FDA CVM report volume, Paint is #153 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #6 of 55. Among breeds with at least 50 reports, its death-coded share ranks #30 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Paint? ▼
The most commonly reported adverse reactions for Paint are Lack of efficacy - NOS (44 reports), Injection site swelling (32 reports), Death by euthanasia (24 reports), Behavioural disorder NOS (23 reports), Anorexia (23 reports).
What drugs are most frequently associated with Paint adverse events? ▼
The drugs most frequently referenced in Paint adverse event reports are Ceftiofur Crystalline Free Acid (41 reports), Omeprazole (40 reports), Pergolide Mesylate (34 reports), Ivermectin(1.55%)/Praziquantel(7.75%) Paste (29 reports), Polysulfated Glycosaminoglycan (23 reports).
What is the average age of Paint in adverse event reports? ▼
The average age of Paint at the time of adverse event reports is 14.3 years, with an average weight of 429.1 kg (946.2 lbs).

Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how the death-coded share and rankings are computed, or read breed-specific reporting patterns and FDA CVM reporting.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Paint (Horse), extract as of July 2026 extract. 386 reports · 53 death-coded (13.7% of reports, not a mortality rate) · #153 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →